Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Company Review of Allergan Inc Including Financial Information, Deals Made, and Partnering Companies over a Five Year Period.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/reports/c26691 ) has announced the addition of Allergan Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products. The company's most notable neurologic product is Botox, used around the world to treat a variety of debilitating  Inc Deals Briefing to their offering

Description

Allergan Inc Deals briefing provides an in-depth in-depth
adj.
Detailed; thorough: an in-depth study.


in-depth
Adjective

detailed or thorough: an in-depth analysis

 view of the 30 deals made by Allergan Inc and its subsidiaries with 29 partnering companies between 2000 and 2005, in a clear and accessible PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format.  format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January January: see month.  2000 and July 2005.

Every deal is fully categorized cat·e·go·rize  
tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es
To put into a category or categories; classify.



cat
, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

The report contains:

a brief company profile including subsidiary names

financial information where disclosed

a deals overview

specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 indexes including deals by partner company, subsidiary company, therapy focus and development stage

a detailed listing of the company's deals and alliances.

Key questions answered

Allergan Inc Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

identifying active partners

tracking competitor activity

benchmarking deals

comparing the finances of different deal types.

Allergan Inc Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Allergan Inc.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who should buy this report

This report is essential reading for board and executive management, and individuals in:

business development

licensing/partnering

deal making

business strategy

marketing and promotion

distribution and manufacturing (including contract services).

Topics Covered

Introduction

About Partneringdesk Deals briefings

Chapter 1: Company profile

Chapter 2: Financial data and deals overview

Chapter 3: Summary of deals

Deals involving Allergan Inc by partner company

Deals involving Allergan Inc by subsidiary

Deals involving Allergan Inc by therapy focus

Deals involving Allergan Inc by development stage

Chapter 4: List of deals

Glossary A term used by Microsoft Word and adopted by other word processors for the list of shorthand, keyboard macros created by a particular user. See glossaries in this publication and The Computer Glossary.  

List of Tables

Table 2.1 Allergan Inc financial summary

Table 2.2 Allergan Inc deals by deal type

Table 2.3 Allergan Inc deals by therapy focus

Table 2.4 Allergan Inc deals by development stage

Table 2.5 Allergan Inc deals by industry sector

Companies Mentioned

Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages.  (until 2002-06-01)

Oculex Pharmaceuticals

For more information visit http://www.researchandmarkets.com/reports/c26691
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 4, 2005
Words:501
Previous Article:Sales in the Sweet Spreads Market in the United States Increased by 11% over a Five Year Period, in 2005 Forecasts Estimate the Market Will Be Worth...
Next Article:How to Successfully Identify the Need for Change within an Organization, Applying It, and Understanding the Impact It Will Have on the Company and...



Related Articles
Eric Brandt Named as Allergan's Corporate Vice President and Chief Financial Officer.
Pyott's Voyage in Lilliput.
ALLERGAN, UPJOHN END MERGER TALKS.
Allergan Reports Second Quarter Operating Results.
Allergan Submits Oral Tazarotene for FDA Approval to Treat Psoriasis; Company Announces Its Partnership Plans for the Tazarotene Molecule.
Allergan Reports Fourth Quarter Operating Results.
Jeffrey Edwards Promoted to Executive Vice President, Finance and Business Development, Chief Financial Officer as Eric Brandt Resigns to Accept...
BRIEFCASE SCENIC WILL LEAVE AIRPORT IN MARCH.
Over 470 Deals and Alliances Announced in Sensory and Dental Diseases between 2001 and 2006.
Over 450 Deals and Alliances Announced in Dermatological Diseases between 2001 and 2006.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles